Medannex

Monoclonal antibody for the treatment of autoimmune diseases

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2009 groups9 employees language medannex.org

Registered entities

Social engagement

Social engagement: 1.7K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

40 investors on record; lead investors include Morningside.

Investor typeCountShare
Venture capital38%
Private equity13%
Other / undisclosed3690%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

Based on job postings tracked across public sources.

Recent activity

19 May 2026
Event
European Cholangiocarcinoma Conference
13 Mar 2026
Recognition
27 Jan 2026
Recognition
Coming soon